KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Receivables - Net (2016 - 2025)

Historic Receivables - Net for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $47.8 million.

  • CareDx's Receivables - Net fell 2819.13% to $47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.8 million, marking a year-over-year decrease of 2819.13%. This contributed to the annual value of $64.6 million for FY2024, which is 2652.51% up from last year.
  • According to the latest figures from Q3 2025, CareDx's Receivables - Net is $47.8 million, which was down 2819.13% from $67.4 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Receivables - Net ranged from a high of $30.0 billion in Q1 2021 and a low of $47.8 million during Q3 2025
  • Moreover, its 5-year median value for Receivables - Net was $66.2 million (2024), whereas its average is $4.8 billion.
  • In the last 5 years, CareDx's Receivables - Net soared by 13124276.08% in 2021 and then tumbled by 9978.23% in 2022.
  • CareDx's Receivables - Net (Quarter) stood at $59.8 million in 2021, then increased by 10.96% to $66.3 million in 2022, then dropped by 23.0% to $51.1 million in 2023, then increased by 26.53% to $64.6 million in 2024, then fell by 25.94% to $47.8 million in 2025.
  • Its last three reported values are $47.8 million in Q3 2025, $67.4 million for Q2 2025, and $71.5 million during Q1 2025.